4
Changes in Ownership
GENELUX Corp Filed Acc 0001209191-23-056237
VP, Clinical Trial Operations sold 18,135 shares at an average $11.60 ($210,431)
From the SEC's structured data for this filing
Trades in this filing
Yu Yong · VP, Clinical Trial Operations
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-17 | Sale : show line 1 in the form | −3,541 | $13.04 | $46,170 | 102,594 | D |
| 2023-11-20 | Sale : show line 2 in the form | −14,594 | $11.26 | $164,261 | 88,000 | D |
| Open-market sales · 18,135 sh · avg $11.60 · $210,431 | ||||||
Loading xslF345X05/doc4.xml…